Resources from the same session
567O_PR - First International Randomized Study in Malignant Progressive Pheochromocytoma and Paragangliomas (FIRSTMAPPP): An academic double-blind trial investigating sunitinib
Presenter: Eric Baudin
Session: Presidential symposium 3
Resources:
Abstract
Slides
Webcast
1557O - Adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients: The CAPTURE study
Presenter: Scott Shepherd
Session: Presidential symposium 3
Resources:
Abstract
Slides
Webcast
LBA8 - Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors
Presenter: Sjoukje Oosting
Session: Presidential symposium 3
Resources:
Abstract
Slides
Webcast
LBA9 - IMpower010: Sites of relapse and subsequent therapy from a phase III study of atezolizumab vs best supportive care after adjuvant chemotherapy in stage IB-IIIA NSCLC
Presenter: Enriqueta Felip
Session: Presidential symposium 3
Resources:
Abstract
Slides
Webcast
Invited Discussant 1557O and LBA8
Presenter: Marie von Lilienfeld-Toal
Session: Presidential symposium 3
Resources:
Slides
Webcast
Invited Discussant LBA9
Presenter: Benjamin Besse
Session: Presidential symposium 3
Resources:
Slides
Webcast